8-K 1 a93940e8vk.htm FORM 8-K DATED OCTOBER 23, 2003 e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  October 23, 2003

CHROMAVISION MEDICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)
         
DELAWARE   000-22677   75-2649072
 
 
(State or other jurisdiction of
incorporation or
organization)		   (Commission File Number)   (IRS Employer Identification
Number)
         
33171 PASEO CERVEZA    
SAN JUAN CAPISTRANO, CA   92675
 
(Address of principal executive offices)   (Zip code)

Registrant’s telephone number, including area code:  (949) 443-3355

 

Item 12. Results of Operations and Financial Conditions
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 99.1

Table of Contents

Item 12. Results of Operations and Financial Conditions

On October 23, 2003, ChromaVision Medical Systems, Inc. (“ChromaVision”) issued a press release regarding ChromaVision’s results of operations for the quarter ended September 30, 2003, and disclosing material non-public information. A copy of the press release is furnished as Exhibit 99.1 to this report.

-1-

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

       
    CHROMAVISION MEDICAL SYSTEM, INC.
     
    (Registrant)
     
Date:  October 24, 2003   /s/  STEPHEN T. D. DIXON
   
    Stephen T. D. Dixon
     
    Executive Vice President and
Chief Financial Officer

-2-

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press release, dated October 23, 2003, issued by ChromaVision Medical Systems, Inc.

-3-